common.study.topics.clinical

Microglial Activation in Inflammatory Bowel Disease

common.study.values.description

Microglial Activation in Inflammatory Bowel Disease

The purpose of this study is to monitor microglial activation in participants with inflammatory bowel disease (IBD) and investigate the relationship that exists between these patients and their risk of acquiring major depressive episodes (MDE). Patients with both IBD and MDE will be subsequently approached to participate in the study.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Radiation - [18F]FEPPA

up to 3 PET Scans ([18F]FEPPA PET scans done 3 to 6 months apart, and one [11C]SL2511.88 PET scan) and 1 MRI

participant.views.study.view.additional

participant.views.study.view.scientific-title

Naturalistic Monitoring of Microglial Activation in Inflammatory Bowel Disease

common.study.values.clinical-trial-id

NCT03487926

participant.views.study.view.id

rb2jAb